EAACI Congress 2024
BackAsthma 4
Saturday 01 Jun, 12:00 PM -
13:00 PM Valencia, Spain
Poster Zone
Thematic Poster Session
12:00
Clinical Characteristics of Patients with Severe Asthma by Different Elevated Biomarkers Classifications: Patients from Spain in the ISAR Registry
12:00
Impact of asthma as a chronic disease on the quality of life of the patient and his family
12:00
Influence of selected cytokines and chemokines on the ventilation efficiency in spirometric examination, in patients with asthma post-COVID-19
12:00
Progressive increase of the intervals between omalizumab administration in severe asthma
12:00
Proposal of an algorithm for asthma diagnosis using molecular biomarkers
12:00
Targeted drug-induced apoptosis in key cellular mediators of allergic asthma as a new treatment strategy
12:00
The Use of Long-acting Muscarinic Antagonist (LAMA) in the Treatment of Asthma: A Tertiary Asthma Center Experience
12:00
Voice biomarkers: a new tool for asthma management
